Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Light-CARMIDO: BX1514M for Hypertrophic Cardiomyopathy
NCT02590809Phase 2Completed
- Sponsor
- Centre Hospitalier Universitaire de Bordeaux
- Start
- Oct 2015
- Primary completion
- Jul 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of midodrine in hypertrophic cardiomyopathy (HCM) (2 arms), sponsored by Centre Hospitalier Universitaire de Bordeaux. Primary endpoint: 6-Minute Walk Test Distance at 15 days. Started Oct 2015; status: completed.
02
Drugs
midodrine
03
Conditions
hypertrophic cardiomyopathy (HCM)
Beyond the preview
Go deeper on NCT02590809.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02590809.